ライフサイエンスコーパス: how to use

1 We describe how to use 3View for studying collagen fibril organizati

2 "specification problem") and the problem of how to use a computer to simulate the progress of the sy

3 psychoeducational intervention, were taught how to use a pillbox, and were given written instruction

4 We describe how to use a plunge freezing apparatus inside of a soft-

5 Finally, we show how to use a reference fluorophore for the correction of

6 Before grasping and demonstrating how to use a specific tool, participants passively viewe

7 In this protocol, we describe how to use a time-correlated single-photon counting (TCS

8 Finally, we describe how to use a user-friendly and easily accessible web ser

9 Here, we show how to use a wave-equation-based imaging method, reverse

10 The challenge is how to use advanced molecular understanding with limited

11 eived in algorithms than in self and suggest how to use algorithms to reveal and correct biased human

12 With P-values, it is not clear how to use an extreme observation (e.g. [Formula: see te

13 developing the ability of the brain to learn how to use an implant may be as important as further imp

14 The focus of this review is on how to use and apply microarrays to these situations.

15 It is critical that surgeons understand how to use and interpret these assays, and they should b

16 ecreased?" Their findings leave us uncertain how to use and interpret these measures to track changes

17 In addition, we provide strategies on how to use and visualize MD simulations to describe and

18 ge in antibiotic stewardship is figuring out how to use antibiotics therapeutically without promoting

19 s are used to develop explicit strategies on how to use Baird's 4n rule on excited-state aromaticity,

20 ation was not independent of tumor features, how to use BRAF V600E to manage mortality risk in patien

21 lines provide conflicting recommendations on how to use bronchodilators to manage childhood acute whe

22 Here, we describe how to use capillary zone electrophoresis (CZE)-MS-based

23 ific 99th percentile upper reference limits; how to use changing concentrations (deltas) to facilitat

24 ng approach more appropriate for determining how to use chromatography most efficiently in one's own

25 ored to their research; and (ii) training in how to use Cloud-based computing resources.

26 This protocol also describes how to use confocal microscopy to visualize mitophagy in

27 However, little is known about how to use coronary atherosclerosis imaging biomarkers t

28 We also showcase how to use CPS analysis to select data generation techno

29 lumina sequencing, and give instructions for how to use custom software to infer the relative transcr

30 In this protocol, we discuss how to use data obtained in affinity purification-mass s

31 This protocol explains how to use DAVID, a high-throughput and integrated data-

32 Authors show how to use Digital Imaging and Communications in Medicin

33 r fluids adequately to a transplant patient; how to use direct vasoactive agents; how to manage the i

34 o provide guidance to oncology clinicians on how to use effective communication to optimize the patie

35 In this paper, the authors demonstrate how to use empirical methods appropriate for EBQP tables

36 These results advance our understanding of how to use Env trimers in multivalent vaccination regime

37 At the same time, critical information on how to use established drugs like nelfinavir and efavire

38 We also show how to use established measures, such as the ratio of in

39 f previous engineering attempts, and propose how to use evolutionary knowledge to advance future rese

40 Finally, we outline how to use exosomes to efficiently deliver siRNA in vitr

41 Although strategies for how to use guidelines to improve care are increasingly w

42 iders seek guidance from economic studies on how to use health care resources wisely.

43 We describe how to use hidden Markov models to evaluate multilocus t

44 In this protocol, we further describe how to use HIEs as an ex vivo model to assess host restr

45 y issues is needed to define better when and how to use HIF-PHD inhibitors compared with already avai

46 Our approach shows how to use high-throughput data to calculate accurately

47 his note we provide a step-to-step guide for how to use HIVcleave to identify the cleavage sites of a

48 This review will discuss how to use imaging in the diagnosis and management of pa

49 The focus then shifts to how to use imaging to assess disease activity and treatm

50 This paper presents our vision of how to use in silico approaches to extract the reaction

51 We show how to use information theory to validate simple stimulu

52 data set with heat rate curves and describe how to use it in general modeling activities and analysi

53 This protocol describes in detail how to use kallisto and bustools in conjunction with a w

54 In addition to new drugs, this must include how to use kidney biopsies for management and not just d

55 rception as probabilistic inference, we show how to use knowledge of the psychophysical task to make

56 First, we show how to use machine learning to combine information from

57 This protocol explains how to use MAGeCKFlute to perform quality control (QC),

58 rate some novel applications of NMF and show how to use masking to inject prior knowledge and desirab

59 Three examples are provided to demonstrate how to use MASSpy: (1) a validation of the MASSpy modeli

60 an introduction for scientific experts about how to use mental models research with intended audience

61 This protocol describes how to use microengraving to screen mouse hybridomas to

62 red their personal experiences and advice on how to use modeling effectively.

63 aluable opportunities for mutual learning on how to use models more effectively as tools to support s

64 We also discuss how to use molecular dynamic simulation to study and pre

65 newer areas of inquiry attempting to define how to use molecular-genetic features of individual tumo

66 Notebooks offering step-by-step guidance on how to use MolLM to extract embeddings for both molecule

67 Here we explain how to use nextPYP-based methods to determine the struct

68 We outline how to use niche construction theory to investigate thes

69 y calcified coronary stenoses, starting with how to use non-invasive and invasive imaging to assess c

70 e fashion, a total of 8 statements regarding how to use omalizumab to treat patients with food allerg

71 how to approach the decision of whether and how to use oral anticoagulation in these patients.

72 We also comment on how to use our knowledge of cell death signaling to impr

73 We illustrate how to use our model to examine previously uncharacteriz

74 Moreover, we show how to use our package to easily perform Connectivity Ma

75 In this protocol, we describe how to use our previously reported gelatin-based O2-cont

76 from plants and provide recommendations for how to use our results.

77 Thus, MBBC users are not required to know how to use Ox, R or C++, but they must be pre-installed.

78 been studied for 200 years, understanding of how to use parallel flows to augment the capabilities of

79 ers and clinicians should carefully consider how to use PFS data in balancing potential benefits agai

80 It especially discusses how to use plasmonic nanoparticles to construct optical

81 We describe how to use PLINK, a tool for handling SNP data, to perfo

82 We explain how to use preserved specimens to address pressing quest

83 Finally, we describe how to use primary vascular cells for transplantation in

84 We detail how to use prior knowledge to bound the number of detect

85 In this review, we discuss how to use probability theory to apply these models to s

86 In this paper, we describe how to use PROBEmer, the computational methods it employ

87 ticle, we provide a step-by-step guidance on how to use PS methods.

88 We describe how to use public protein databases and molecular modeli

89 A Readme file, which explains how to use pViz with examples, is available as Supplemen

90 This review describes how to use quasi-steady state approximations in the righ

91 In addition, new video tutorials describe how to use RDP features.

92 rrent work-up of lymphocytosis and highlight how to use recently identified prognostic tools to strat

93 We show how to use reference 450k datasets to estimate cell type

94 We show how to use relativistic motion to generate continuous va

95 icians and patients are often confused about how to use results of studies in individual cases.

96 This protocol describes in detail how to use Ribose-Map to analyze ribonucleotide sequenci

97 However, if, when, and how to use rifampin remains a matter of debate.

98 s an overview of the algorithm and describes how to use Scalpel to perform highly accurate indel call

99 In this protocol we describe how to use several popular features of Vaa3D, including

100 Here we describe how to use sigQC, a tool that enables a streamlined, sys

101 Fourth, we provide an overview of how to use simplicial sets, highlighting specific metric

102 This study demonstrates how to use simulated diffractograms to connect the contr

103 determine pore-membrane binding and discuss how to use single-channel current recordings and dye flu

104 In this protocol, we show how to use small-scale transient transfection and fluore

105 ich entrants submitted strategies specifying how to use social learning and its asocial alternative (

106 In this Viewpoint we describe how to use SoMe platforms (e.g., Twitter, podcasts, and

107 We further show how to use species, item, or gene count data to refine e

108 Here, we provide guidance on how to use SRM techniques advantageously for investigati

109 Here we show how to use statistical mechanics to construct operators

110 vironment, it has become important to assess how to use such data to estimate infectious disease risk

111 inding sites, suggesting that adjustments of how to use such metrics are required.

112 Here, we show how to use suffix array-based methods that have formed t

113 tration depth and signal-to-noise ratio, and how to use surface plasmon resonance (SPR) to amplify fl

114 how signaling goes awry to cause cancer, and how to use targeted molecular agents to treat both inher

115 As we continue to learn how to use targeted therapies in the context of genomic

116 r in TensorFlow (version 2) is developed and how to use TensorBoard to monitor training progress, to

117 nonlinear interactions, but it was not clear how to use that information to obtain quantitative insig

118 Here, we detail how to use the 'novel tank' test to assess behavioral in

119 We present a set of protocols showing how to use the 3DNA suite of programs to analyze, rebuil

120 We demonstrate how to use the computational environment R to integrate

121 entists, a step-by-step guide is provided on how to use the current web server to generate their desi

122 of when to order testing, what to order and how to use the data in real time remains an area for fut

123 Examples of how to use the database to identify Drosophila genes rel

124 njector is prescribed, education on when and how to use the device should be provided.

125 el activity, and include online vignettes on how to use the Diel.Niche package.

126 user manual contain detailed instructions on how to use the different components of software and data

127 erstands the concept of occupancy factor and how to use the dosing charts, our model facilitates appl

128 We outline how to use the ecomechanical paradigm using drag-induced

129 when and how to introduce fluorine but also how to use the effects of fluorine for a desirable resul

130 sed CR tone alignment strategies and explain how to use the ERB-based model in experiments, clinical

131 This article illustrates how to use the estimands framework by applying it to an

132 exists in each marker interval, we describe how to use the expectation-maximization algorithm to exa

133 interval at most one crossover, we describe how to use the expectation-maximization algorithm to exa

134 We show how to use the expectation-maximization algorithm to fin

135 In this work, we show how to use the Gauss linking integral (GLN) in the form

136 l as its recent development, particularly in how to use the general formulation of PseAAC to reflect

137 We provide a proof-of-concept application of how to use the herein-developed affinity ligand in seque

138 Not all participants could learn how to use the Icare HOME device, but for those who coul

139 However, how to use the information of known protein complexes is

140 This protocol covers how to use the intrinsic circular dichroic properties of

141 We describe how to use the Kimura distribution in mitochondrial gene

142 Finally, we show how to use the library to extract SWATH data with the op

143 the water splitting chemical mechanisms and how to use the model system to test device engineering d

144 n of the method and give several examples of how to use the modules in specific cases.

145 The authors show how to use the MSM parameter estimates and contrasts to

146 In particular, we show how to use the multigeneration-wrinkled substrate for se

147 ed description of the FLOW-MAP algorithm and how to use the open-source R package FLOWMAPR via its GU

148 beled coalescent tree (PLCT) and demonstrate how to use the PLCT to evaluate the feasibility of a gen

149 The user can quickly see how to use the pressure for speed or for more theoretica

150 effector transgenes in tissues of interest, how to use the Q system in conjunction with the GAL4 sys

151 ssues will be experimentally manipulated and how to use the Q system to perform mosaic analysis.

152 assays has led to potential confusion about how to use the results for clinical decision making.

153 forward, one of the many challenges will be how to use the results of molecular profiling to guide p

154 Here we describe how to use the scanning micro-optrode technique (SMOT) t

155 ain how to prepare model and data files, and how to use the software SBMLsimulator in combination wit

156 of imaging findings associated with it, and how to use the specific terminology derived from the Atl

157 inst new viral strains is vital for deciding how to use the stockpile.

158 After a run-in period to teach participants how to use the study pump and continuous glucose monitor

159 A video tutorial on how to use the Survboard leaderboard is available on You

160 ish SoNar-expressing cells, and then discuss how to use the system to quantify the intracellular redo

161 We describe how to use the technique for cells (Xenopus oocyte), tis

162 the reader will find a brief description on how to use the various scripts and programs.

163 This protocol describes how to use the viral protein families catalog ( approxim

164 entists, a step-by-step guide is provided on how to use the web server to obtain the desired results

165 This protocol is a step-by-step guide on how to use the Web-server predictors in the Cell-PLoc pa

166 step-by-step protocol guide was provided on how to use the web-server to get the desired results wit

167 f senescence and offering recommendations on how to use them as biomarkers.

168 ibe how these human-powered systems work and how to use them effectively in scientific domains.

169 ir application, and provide a walkthrough of how to use them for ecological applications.

170 and insect cells as well as instructions on how to use them in stable isotope dilution mass spectrom

171 iewers, readers, and guideline developers in how to use them to assess risk of bias and applicability

172 benefit our studies of individual genes, and how to use them to improve our understanding of developm

173 est suit their needs, where to get them, and how to use them to their best advantage.

174 d synthesis, as well as practical details of how to use them with living cells.

175 ral-fluid-based HIV test kits, instructed on how to use them, and encouraged to distribute a test kit

176 ed them rather than clear instructions about how to use them.

177 rmative resources for scientists-IF you know how to use them.

178 As an example of how to use these approaches, in this article we use a co

179 However, how to use these biomarkers is still being debated, espe

180 eractions were analyzed to better understand how to use these characteristics to extract how biomolec

181 our objective was to provide a framework for how to use these data correctly in a spatial meta-popula

182 However, the remaining challenge is how to use these data effectively for pharmacogenomics.

183 How to use these databases effectively is an open questi

184 e already established, guidance is needed on how to use these drugs in patients already receiving ant

185 ment between health care providers regarding how to use these indices.

186 esults, it remains unclear for practitioners how to use these methods and choose between them in a pr

187 Clinicians need to know how to use these modalities and monitor them properly, e

188 Then we describe how to use these nanostructures to manipulate local memb

189 We conclude with considerations on how to use these new agents to treat non-AIDS-defining c

190 tes, and we provide a framework for when and how to use these outcome measures.

191 We then discuss how to use these parameters in the optimal design of pea

192 e such as PLINK, R or Haploview, we describe how to use these popular tools for handling single-nucle

193 everal other FST estimators, and we describe how to use these statistics to produce a rooted tree of

194 tegies have shown promise, but guidelines on how to use these strategies optimally are lacking.

195 We also presented a framework to outline how to use these three algorithms to obtain collaborativ

196 n a cyclical process of deciding whether and how to use third-party resources.

197 This protocol describes how to use this approach to determine how efficiently a

198 Finally, we outline how to use this approach to investigate which targets po

199 ers, and will hopefully provide insight into how to use this biomarker more productively by distingui

200 rotocol we describe the synthesis of CS1 and how to use this chemical tool to investigate intracellul

201 ol, we describe the synthesis of MitoPY1 and how to use this chemical tool to visualize mitochondrial

202 s to ascertain the source of vision loss and how to use this clinical information to help guide the s

203 We describe how to use this DNA labeling in parallel with multiplexe

204 We further show how to use this framework to create simple models with a

205 sponsible for complex disease phenotypes and how to use this information to develop new and specific

206 alysts using operando Raman spectroscopy and how to use this information to implement improved molecu

207 Five case studies are provided to illustrate how to use this information to inform responses to real-

208 We show how to use this insight to improve the design of peroxir

209 ecial focus on the PI3K pathway in DLBCL and how to use this knowledge therapeutically.

210 We demonstrate how to use this knowledge to refine these methods and im

211 Here, we describe how to use this method to label and/or genetically manip

212 We show how to use this package to simulate a gene expression da

213 form, in vitro detection of ATP and GTP, and how to use this platform to realize intracellular ATP an

214 specific studies are needed to better define how to use this promising biomarker in various contexts

215 We also describe how to use this protocol for exploratory study on connec

216 A current challenge is how to use this structural information for the rational

217 This protocol describes how to use this system, which provides a powerful tool f

218 This protocol describes how to use this system; the time required for lysing the

219 However, how to use those datasets to dissect the cis-regulatory

220 linicians to have a fuller sense of when and how to use time-limited trials.

221 This protocol describes in detail how to use TopHat and Cufflinks to perform such analyses

222 itional mouse model of epilepsy, we describe how to use transcranial US to disrupt electrographic sei

223 Here, we describe how to use Transmission Electron Microscope (TEM) to obt

224 This review focuses first on how to use troponin, which at present is the best valida

225 or isolated transitions and some examples of how to use variations of g-factors with wavelength are d

226 domains of life and provides an example for how to use various experimental techniques to rapidly le

227 ar tutorials to help users better understand how to use various IMG functions and tools for their res